Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCANN SILVER is a terpene-enriched medical cannabis oil product line developed by Bazelet Group, specifically tailored for the geriatric population. The formulation consists of standardized cannabis oils available in various THC/CBD ratios (such as 1:28, 3:15, 5:5, and 10:2) and is enriched with patented terpene profiles adapted for the physiology of seniors. It is designed to address functional and emotional challenges common in elderly patients, including chronic pain, insomnia, anxiety, and psychomotor attention deficiency. The product is administered sublingually and utilizes MCT oil as a carrier. Its therapeutic effect is based on the 'entourage effect,' where cannabinoids and terpenes work synergistically to modulate the endocannabinoid system and neurotransmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BCANN SILVER.